ImmunityBio, Inc. IBRX Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s change in AR?
- ImmunityBio, Inc. (IBRX) reported change in AR of $700K in Q1 2026.
- How has ImmunityBio, Inc.'s change in AR changed year-over-year?
- ImmunityBio, Inc.'s change in AR decreased by 95.2% year-over-year, from $14.67M to $700K.
- What does change in AR mean?
- The difference in the amount of money owed to the company by customers between two periods.
- How do you interpret change in AR?
- A consistent increase relative to revenue may signal collection issues or aggressive revenue recognition.
- How does change in AR compare across companies?
- Should generally track with revenue growth; significant deviations suggest credit risk.